Welcome to the 2025 ISCD Conference on Skeletal Health Assessment!
AGENDA: Scroll down to the agenda below and click on the name of each session for more information. All times are EST and the schedule is subject to change so please check back frequently for the most up-to-date schedule.
PRE & POST CONFERENCE COURSES: A selection of Pre- and Post-Conference Courses are also being offered. Visit the Conference Registration page and scroll down for more information. These courses require a separate registration from the Conference.
LIVESTREAM: For those attending in-person, selecting the Livestream option within each session is NOT permitted.
SESSION RECORDINGS: Recordings are ONLY offered for those seeking ACCME credits, and will be available approximately 24-48 hours after each session.
CLAIMING CREDITS: Participants may claim ONLY one type of credit. For more details visit the CME Info page.
Thursday, February 20
Thu, Feb 20 @ 7:30am-7:00pm EST
Registration
Visit the registration desk located in the foyer
Thu, Feb 20 @ 8:00-9:00am EST
DXA Beyond BMD Measurement
Overview
This session will review currently available DXA software features that may not be integrated into routine clinical practice along with companion software that expands the utility of DXA imaging. Finally, discussion of potential opportunities to enhance or extend the technology.
OBJECTIVES
- Identify currently available software features that have clinical application
- Review evolving DXA applications that may have future clinical utility
- Discuss the potential of DXA to expand into new clinical areas
LOCATION
Georgian room
Speaker(s)
Diane Krueger, BS, CBDT, Researcher
Thu, Feb 20 @ 9:15-10:15am EST
DXA in Children Treated with Bisphosphonates
Overview
In growing bone, administration of bisphosphonate yields differing effects based on medical condition, age, skeletal site measured, and therapeutic regimen.
OBJECTIVES
- Describe appearance of bisphosphonate treatment at measured body sites in treated children
- Examine BP treatment effects over time in children with different conditions
- Review bisphophonate treatment approaches used in pediatrics.Identify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT, Director of Radiology Research Operations
Thu, Feb 20 at 10:15-10:45am EST
Exhibit Break
Exhibits are located in Statler
Thu, Feb 20 @ 10:45-11:45am EST
Challenges when Reporting BMD for Less Than 4 Vertebral Bodies
Overview
The consideration of how to best report less than 4 vertebrae for spine BMD is frequently discussed. This issue was addressed during the last position development conference. This lecture will review how this should best be evaluated and reported along with taking into account trabecular bone score reporting in this situation as well.
OBJECTIVES
- Identify the best way to report less than 4 vertebrae on a spine BMD
- Distinguish between the different methods in which LSC can be reported in this situation
- Determine how TBS should be evaluated when less than 4 vertebrae are evaluated. Identify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
Dr. Harold Rosen, MD, CCD, Director of the Osteoporosis Prevention and Treatment Center
Thu, Feb 20 at 12:15-1:15pm EST
Product Theater - Sponsored by Medimaps
Product Theaters take place in Georgian
Thu, Feb 20 at 1:45-2:45pm EST
Optimal Use of Anabolic and Antiresorptive Therapies in the Treatment of Postmenopausal Osteoporosis
Overview
An update on anabolic and antiresorptive therapies and the importance of drug sequence.
OBJECTIVES
- Understand the benefits and risks of long-term therapy with any single agent
- Determine the effects of discontinuing the various osteoporosis medications
- Be familiar with the distinct effects of the various drug sequences in osteoporosis therapy
LOCATION
Georgian room
Speaker(s)
Benjamin Leder, Professor of Medicine
Thu, Feb 20 at 2:45-3:15pm EST
Exhibit Break
Exhibits are located in Statler
Thu, Feb 20 at 3:15-4:15pm EST
Preoperative Spine Population / Maximizing
Overview
The importance of optimization of bone health prior to spine surgery is well recognized and being addressed regularly. This lecture will focus on the best ways to assess and enhance bone health prior to spine surgery for improved outcomes.
OBJECTIVES
- Describe how to best assess bone health prior to spine surgery
- Determine which treatment option should be considered in different situations along with potential side effects
- Explain what treatment length should be expected along with potential improvement in outcomes
LOCATION
Georgian room
Speaker(s)
Paul A. Anderson, MD, MS, Emeritus Professor of Orthopedics
Thu, Feb 20 at 4:30-5:30pm EST
Sarcopenia, Osteoporosis and Fractures: Perspectives on Musculoskeletal Aging of an Aging Musculoskeletal Clinical Researcher
Overview
Sarcopenia, the age-related loss of muscle mass and function, is often considered in the context of osteoporosis and fractures. Despite this, progress in clinical recognition and treatment of sarcopenia has been limited. Sarcopenia today seems comparable to osteoporosis prior to 1990; a disease without widespread clinical diagnosis for which no pharmacologic therapy exists. Moreover, the pathogenesis of sarcopenia and osteoporosis are strikingly similar. Nonetheless, consideration of sarcopenia by osteoporosis clinicians can be done today; reasonable current, and potential future, clinical approaches will be considered.
OBJECTIVES
- Make use of a syndrome approach to reducing “osteoporosis-related” fractures
- Appreciate challenges in operationalizing the diagnosis of sarcopenia
- Summarize rational approaches to non-pharmacologic fracture risk reduction therapy including calcium, vitamin D, protein and exercise/falls risk reduction
LOCATION
Georgian room
Speaker(s)
Neil Binkley, MD, CCD, Professor of Medicine
Thu, Feb 20 at 5:45-6:45pm EST
Stump the Experts
Overview
Difficult bone cases will be reviewed with salient teaching points discussed. A panel of experts will provide opinions as well.
OBJECTIVES
- Identify how to navigate difficult metabolic bone cases
- Distinguish between the best tests to order in different clinical scenarios
- Describe which medications would be best utilized in distinct situations
LOCATION
Georgian room
Speaker(s)
John J. Carey, MBBChBAO, MS, CCD, FRCPI, Physician in Rheumatology, Osteology, and Medicine / Professor in Medicine
Thu, Feb 20 at 7:00-10:00pm EST
Opening Reception
Join us for the Opening Reception in Statler and the foyer
Friday, February 21
Fri, Feb 21 @ 7:30am-6:30pm EST
Registration
Visit the registration desk located in the foyer
Fri, Feb 21 @ 8:00-9:00am EST
Fracture Detection Using AI
Overview
Artificial intelligence is well recognized as an emerging and vital part of assessing bone health. This lecture will focus on how we can best utilize and glean important information from radiology films to assess fracture presence and increased future risk.
OBJECTIVES
- Identify how to best assess the use of AI on the use of radiographs to assess for fractures
- Determine the limitations of using AI in this setting
- Distinguish how to best utilize this technology for the future
LOCATION
Georgian room
Speaker(s)
Ali Guermazi, MD, PhD, MSc, Professor of Radiology & Medicine
Fri, Feb 21 @ 9:15-10:15am EST
Clinical Pearls in Paget's Disease: Diagnosis and Treatment
Overview
Paget's disease is a skeletal growth disorder in which significant abnormalities can occur. This session will help with the identification and treatment of these abnormalities.
OBJECTIVES
- Understand the pathophysiology of Paget's Disease
- Become familiar with the radiologic features of Paget's Disease
- Understand the management of Paget's DiseaseIdentify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
Gary Edelson, M.D.,
Fri, Feb 21 @ 10:15-10:45am EST
Exhibit Break
Exhibits are located in Statler
Fri, Feb 21 @ 10:45-11:45am EST
Living with Hypoparathyroidism: What's New and What is Upcoming
Overview
Hypoparathyroidism is a rare but serious disorder with potentially very significant adverse outcomes. This lecture will focus on the importance of its proper identifcation and treatment through the discussion of cases along with a review of the literature. Current and future treatment options will be reviewed.
OBJECTIVES
- Determine how to best assess and treat patients with hypoparathyroidism
- Distinguish between the potential risks and benefits of older versus newer treatment options
- Identify the concerns of preventing potential long term sequelae in patients not treated optimally
LOCATION
Georgian room
Speaker(s)
Lynn A. Kohlmeier, MD, Director
Fri, Feb 21 @ 12:15-1:15pm EST
Product Theater - Industry Sponsored Event (NON-CME)
Product Theaters take place in Georgian
Fri, Feb 21 @ 1:45-2:45pm EST
Vitamin D Controversies
Overview
Vitamin D is essential to bone health. Controversies exist in this field regarding optimal replacement. Recent Endocrine Society Guidelines will be reviewed along with how this information should best be taken into context in the treatment of our patients with metabolic bone disorders.
OBJECTIVES
- Identify how to best screen and treat patients at risk for vitamin D deficiency
- Describe recent guidelines on this topic
- Determine how to best utilize this information in clinical practice and patient care. Identify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
Alan Malabanan MD, Clinical Associate Professor, Endocrinology, Diabetes, Nutrition & Weight Management
Fri, Feb 21 @ 2:45-3:15pm EST
Exhibit Break
Exhibits are located in Statler
Fri, Feb 21 @ 3:15-4:15pm EST
Assessment of BMD in Sports Medicine
Overview
Many important diagnostic evaluations by sports medicine specialists are important for the non-orthopedic clinician. Sports medicine is more of a blend of specialities rather than a single specialty, and the care of the athlete requires understanding them.
OBJECTIVES
- How to approach Relative Energy Deficiency in Sport
- How to work around injuries to allow an athlete to safely exercise
- How to prevent injury Identify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
Gillian Wooldridge, DO, CCD,
Fri, Feb 21 @ 4:30-5:30pm EST
Fracture Liaison Service Updates
Overview
Fracture Liaison Services are crucial to helping prevent future fractures in very high risk patients. The ideal way in which to implement this service remains debatable. The success and data available on the current FLS program being implemented at MGH to date with the use of Zoledronate early on will be discussed.
OBJECTIVES
- Recognize FLS as an effective mechanism to narrow osteoporosis treatment gap and fracture secondary prevention as a critical opportunity to identify and treat at-risk patients
- Evaluate the safety of zoledronic acid administered during initial fracture hospitalization and its effectiveness in improving osteoporosis treatment rate
- Discuss clinical outcomes of inpatient zoledronic acid for patients admitted for hip fracture
LOCATION
Georgian room
Speaker(s)
WuQiang Fan, Clinical Director of Fracture Liaison Service
Fri, Feb 21 @ 5:45-6:45pm EST
Preventing Osteoporosis: Are We Missing an Opportunity?
Overview
Osteoporosis is a very significant disease with increased fracture risk. This session will explore various ways to approach prevention in patients.
OBJECTIVES
- Understand the magnitude of changes in bone density and microarchitecture that occur during the menopause transition
- Know how to identify women at high risk for developing osteoporosis
- Appreciate a long-term for preventing osteoporosis
LOCATION
Georgian room
Speaker(s)
Michael R. McClung, MD, FACP, FACE, FASBMR,
Fri, Feb 21 @ 7:00-10:00pm EST
Awards & Annual Business Meeting
The ISCD Annual Business Meeting and Awards Ceremony will feature highlights from the Society and recognize our 2024 and 2025 ISCD Award recipients as well as our Best Case Award recipient. Please join us to hear the officers' report and Dr. Angela Man-Wei Cheung, MD, PhD, FRCPC, CCD give her Presidential Address.
Saturday, February 22
Sat, Feb 22 @ 7:30am-6:00pm EST
Registration
Visit the registration desk located in the foyer
Sat, Feb 22 @ 8:00am-9:00am EST
Challenges of Osteoporosis Treatments Across the Spectrum of CKD
Overview
Osteoporosis and an increase in fracture risk occurs across different GFR levels. At higher stages of CKD, proper identification of the correct type of metabolic bone disorder being assessed is essential for proper treatment. This lecture will focus on how to best identify and treat patients at risk for future fracture at different stages of CKD.
OBJECTIVES
- Describe how to best assess bone health and fracture risk across different stages of CKD
- Distinguish between the different types of metabolic bone disorders that can occur at lower GFR levels
- Identify which treatments for fracture risk reduction should be considered in different scenarios related to CKD.Identify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
Paul Miller, MD, HDSc (honorary), Medical Director
Sat, Feb 22 @ 9:15am-10:15am EST
Treat to Target
Overview
The concept of treat to target is well recognized across multiple fields of medicine and for some time now has been discussed in the arena of osteoporosis. This lecture will focus on the concept of treat to target in patients who warrant treatment for being at high risk for fracture along with which goals should be assessed and discussed with the patients for optimizing treatment.
OBJECTIVES
- Identify what is considered treat to target in osteoporosis treatment
- Describe the newer position statement published in this field
- Determine how to best assess patients on treatment over time along with treatment goals.Identify currently available software features that have clinical application
LOCATION
Georgian room
Speaker(s)
E. Michael Lewiecki, MD, FACP, FACE, CCD, Director
Sat, Feb 22 @ 10:45am-12:00pm EST
Clinical Conundrums & Challenging Cases in the Bone Health of Transgender Individual
Overview
Transgender and gender diverse (TGD) people are at increased risk for bone loss due to changes in their hormonal milieu. The ISCD recommends screening for low bone density in TGD people especially in those who are at high risk for bone loss and/or may not reach peak bone mass. This case based session will discuss different clinical situations where bone density screening should be performed and when treatment should be considered.
OBJECTIVES
- Review ISCD guidelines for screening for low bone density in transgender and gender diverse people
- List conditions that might put transgender and gender diverse people at increased risk for bone loss
- Discuss potential treatment options for transgender and gender diverse people
LOCATION
Georgian room
Speaker(s)
Vin Tangpricha, MD, PhD, Professor of Medicine, Eminent Physician
Access Date | Quiz Result | Score | Actions |
---|